NDC11 64764051550
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 64764-0515-50 | 64764-0515 |
| 64764-515-50 | 64764-515 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADZYNMA | APADAMTASE ALFA | TAKEDA PHARMACEUTICALS AMERICA, INC. | 22728e96-efa0-46c1-bdd1-ad89a796d5e3 | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | 64764-515-50 64764051550 |
| VONVENDI | VON WILLEBRAND FACTOR (RECOMBINANT) | Takeda Pharmaceuticals America, Inc. | 53b6d198-6175-4a26-8606-dc0d2a0f12d6 | 2026-07-28 | Warnings, Adverse reactions | 64764-515-50 64764051550 |
| ADYNOVATE | ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED | Takeda Pharmaceuticals Amercia, Inc. | ef290433-997f-4e98-86d6-42f6a99d6d18 | 2026-05-28 | Warnings, Adverse reactions | 64764-515-50 64764051550 |
| RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) | Takeda Pharmaceuticals America, Inc. | f5070a92-96b8-476a-a2dc-18b22d95e5e0 | 2026-05-12 | Warnings, Adverse reactions | 64764-515-50 64764051550 |
| CEPROTIN | PROTEIN C CONCENTRATE HUMAN | Takeda Pharmaceuticals America, Inc. | 926914a9-78b2-40ea-b37d-2a55c09bf275 | 2025-12-04 | Warnings, Adverse reactions | 64764-515-50 64764051550 |
| Cinryze | HUMAN C1-ESTERASE INHIBITOR | Takeda Pharmaceuticals America, Inc. | d53a911f-070d-498a-8a61-baab72b9d0fe | 2025-11-28 | Warnings, Adverse reactions | 64764-515-50 64764051550 |
| ADVATE | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | Takeda Pharmaceuticals America, Inc. | 80fa03d2-cd4c-4155-9b57-1396c4fa42da | 2025-04-03 | Warnings, Adverse reactions | 64764-515-50 64764051550 |
| RECOMBINATE | ANTIHEMOPHILIC FACTOR RECOMBINANT | Takeda Pharmaceuticals America, Inc. | d99348b1-edad-41de-aed9-903a6f9f279f | 2025-04-03 | Warnings, Adverse reactions | 64764-515-50 64764051550 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.